Cutaneous Manifestations of COVID-19 in Children
DOI:
https://doi.org/10.66344/jpad.31.1.2021.1707Abstract
The severe acute respiratory syndrome coronavirus 2 (SARSâ€CoVâ€2) and the ensuant disease coronavirus disease 2019 (COVIDâ€19), has erupted as global pandemic. Clinical presentation, course and outcome of disease is different in children. Besides, respiratory symptoms, patients of COVID-19 can present with diverse cutaneous manifestations seen in 0.2% to 20% of patients, and 3.4% of children. Common dermatologic findings include pseudochilblain (COVID toes, maculopapular (morbilliform) exanthem, urticaria, vesicular rash, erythema multiforme and Kawasaki disease-like inflammatory multisystemic syndrome. Cutaneous involvement usually occurs concurrently with the systemic symptoms; nonetheless, these can follow or precede the systemic features. Any correlation between COVID-19 severity and cutaneous manifestations remains speculative. These cutaneous changes may guide to early diagnosis and treatment of COVID-19.Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.